These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 28952001)

  • 1. Exposures to arsenite and methylarsonite produce insulin resistance and impair insulin-dependent glycogen metabolism in hepatocytes.
    Zhang C; Fennel EMJ; Douillet C; Stýblo M
    Arch Toxicol; 2017 Dec; 91(12):3811-3821. PubMed ID: 28952001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arsenite and its trivalent methylated metabolites inhibit glucose-stimulated calcium influx and insulin secretion in murine pancreatic islets.
    Huang M; Douillet C; Stýblo M
    Arch Toxicol; 2019 Sep; 93(9):2525-2533. PubMed ID: 31332465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenite and methylarsonite inhibit mitochondrial metabolism and glucose-stimulated insulin secretion in INS-1 832/13 β cells.
    Dover EN; Beck R; Huang MC; Douillet C; Wang Z; Klett EL; Stýblo M
    Arch Toxicol; 2018 Feb; 92(2):693-704. PubMed ID: 28956099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms of the diabetogenic effects of arsenic: inhibition of insulin signaling by arsenite and methylarsonous acid.
    Paul DS; Harmon AW; Devesa V; Thomas DJ; Stýblo M
    Environ Health Perspect; 2007 May; 115(5):734-42. PubMed ID: 17520061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
    Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
    Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exposure to inorganic arsenic and its methylated metabolites alters metabolomics profiles in INS-1 832/13 insulinoma cells and isolated pancreatic islets.
    Li YY; Douillet C; Huang M; Beck R; Sumner SJ; Styblo M
    Arch Toxicol; 2020 Jun; 94(6):1955-1972. PubMed ID: 32277266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-191 blocking the translocation of GLUT4 is involved in arsenite-induced hepatic insulin resistance through inhibiting the IRS1/AKT pathway.
    Li W; Wu L; Sun Q; Yang Q; Xue J; Shi M; Tang H; Zhang J; Liu Q
    Ecotoxicol Environ Saf; 2021 Jun; 215():112130. PubMed ID: 33743404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylated trivalent arsenicals are potent inhibitors of glucose stimulated insulin secretion by murine pancreatic islets.
    Douillet C; Currier J; Saunders J; Bodnar WM; Matoušek T; Stýblo M
    Toxicol Appl Pharmacol; 2013 Feb; 267(1):11-5. PubMed ID: 23261974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selenium modifies the metabolism and toxicity of arsenic in primary rat hepatocytes.
    Styblo M; Thomas DJ
    Toxicol Appl Pharmacol; 2001 Apr; 172(1):52-61. PubMed ID: 11264023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of insulin-dependent glucose uptake by trivalent arsenicals: possible mechanism of arsenic-induced diabetes.
    Walton FS; Harmon AW; Paul DS; Drobná Z; Patel YM; Styblo M
    Toxicol Appl Pharmacol; 2004 Aug; 198(3):424-33. PubMed ID: 15276423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of insulin resistance in IRS-2-deficient hepatocytes.
    Valverde AM; Burks DJ; Fabregat I; Fisher TL; Carretero J; White MF; Benito M
    Diabetes; 2003 Sep; 52(9):2239-48. PubMed ID: 12941762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged inorganic arsenite exposure suppresses insulin-stimulated AKT S473 phosphorylation and glucose uptake in 3T3-L1 adipocytes: involvement of the adaptive antioxidant response.
    Xue P; Hou Y; Zhang Q; Woods CG; Yarborough K; Liu H; Sun G; Andersen ME; Pi J
    Biochem Biophys Res Commun; 2011 Apr; 407(2):360-5. PubMed ID: 21396911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sar1, Ile4, Ile8]-angiotensin II Potentiates Insulin Receptor Signalling and Glycogen Synthesis in Hepatocytes.
    Sanni SJ; Lyngsø C; Gammeltoft S; Hansen JL
    Basic Clin Pharmacol Toxicol; 2018 May; 122(5):460-469. PubMed ID: 29136335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of arsenic in human liver: the role of membrane transporters.
    Drobná Z; Walton FS; Paul DS; Xing W; Thomas DJ; Stýblo M
    Arch Toxicol; 2010 Jan; 84(1):3-16. PubMed ID: 20020104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taurine improves low-level inorganic arsenic-induced insulin resistance by activating PPARγ-mTORC2 signalling and inhibiting hepatic autophagy.
    Gao N; Yao X; Jiang L; Yang L; Qiu T; Wang Z; Pei P; Yang G; Liu X; Sun X
    J Cell Physiol; 2019 Apr; 234(4):5143-5152. PubMed ID: 30362509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalent role of the insulin receptor isoform A in the regulation of hepatic glycogen metabolism in hepatocytes and in mice.
    Diaz-Castroverde S; Baos S; Luque M; Di Scala M; González-Aseguinolaza G; Gómez-Hernández A; Beneit N; Escribano O; Benito M
    Diabetologia; 2016 Dec; 59(12):2702-2710. PubMed ID: 27600278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigallocatechin-3-gallate ameliorates insulin resistance in hepatocytes.
    Ma SB; Zhang R; Miao S; Gao B; Lu Y; Hui S; Li L; Shi XP; Wen AD
    Mol Med Rep; 2017 Jun; 15(6):3803-3809. PubMed ID: 28393248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High glucose reduces hepatic glycogenesis by suppression of microRNA‑152.
    Zhao X; Lu Y; Wang F; Dou L; Wang L; Guo J; Li J
    Mol Med Rep; 2014 Oct; 10(4):2073-8. PubMed ID: 25070263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte growth factor inhibits insulin-stimulated glycogen synthesis in primary cultured hepatocytes.
    Kaibori M; Kwon AH; Teshima S; Nakanishi H; Kitano T; Kamiyama Y; Okumura T
    J Hepatol; 2003 Apr; 38(4):407-13. PubMed ID: 12663230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Environmental arsenic as a disruptor of insulin signaling.
    Paul DS; Devesa V; Hernandez-Zavala A; Adair BM; Walton FS; Drobnâ Z; Thomas DJ; Styblo M
    Met Ions Biol Med; 2008; 10():1-7. PubMed ID: 20467584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.